COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: The intervention group in addition to receiving a standard nationwide medication [2 tablets of Hydroxychloroquine sulfate 200 mg as a single dose and 2 tablets of K
Sponsors
Shooshtar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Mild to moderate disease Positive polymerase chain reaction (PCR) test Lung involvement based on CT scan Hospitalization
Exclusion criteria
Exclusion criteria: Patient death Sensitivity to inhalation of the drug Intolerance of nebulizer Physician's diagnosis of not participating in the study Pregnancy and lactation Use of angiotensin-converting enzyme inhibitor Severe renal, hepatic, respiratory and cardiovascular failure Taking cytotoxic or corticosteroid drugs Transfer to another hospital
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of oxygen saturation. Timepoint: Before the start of the intervention, 5 consecutive days during the intervention and one day after the intervention. Method of measurement: Pulse oximeter.;Respiratory rate. Timepoint: Before the start of the intervention, 5 consecutive days during the intervention and one day after the intervention. Method of measurement: Count the respiratory rate per minute. | — |
Secondary
| Measure | Time frame |
|---|---|
| C-Reactive Protein. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;White blood cell. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Neutrophil. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Lymphocytes. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Red blood count. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Erythrocyte sedimentation rate. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Hatami
Shooshtar University of Medical Sciences
Outcome results
None listed